STUDY ON SAFETY AND EFFECTIVENESS OF ORAL TOFACITINIB IN PATIENTS WITH REFRACTORY MODERATE TO SEVERE ATOPIC DERMATITIS. International Research Journal of Pharmacy, [S. l.], v. 9, n. 8, p. 125–128, 2018. DOI: 10.56802/gzfvmr94. Disponível em: https://irjponline.org/index.php/irjp/article/view/3224. Acesso em: 31 may. 2026.